OIT-BRAVE Questionnaire: Development and clinical implementation of a screening instrument for patient-reported difficulties during oral immunotherapy.
J Allergy Clin Immunol Pract
; 2024 Jun 06.
Article
en En
| MEDLINE
| ID: mdl-38851488
ABSTRACT
The OIT-BRAVE questionnaire was developed to serve as a clinical screening tool to identify patients who may be experiencing adverse effects with oral immunotherapy.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
J Allergy Clin Immunol Pract
Año:
2024
Tipo del documento:
Article